Event-Driven Stocks

ImmunoGen, Inc.

Healthcare · Pharmaceutical Preparations · MA · SEC filings ↗ · Compare ⊕

Signs● 2 good● 3 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY22FY21FY20FY19FY18FY17
Revenue$108.8M$69.9M$132.3M$82.3M$53.4M$28.5M
Operating income−$220.9M−$125.1M−$22.4M−$92.2M−$161.4M−$12.9M
Net income−$222.9M−$139.3M−$44.4M−$104.1M−$168.8M−$17.3M
Total assets$348.9M$525.8M$355.1M$235.3M$295.4M$294.7M
Total liabilities$193.1M$200.2M$265.5M$311.4M$284.4M$312.6M
Equity$155.8M$325.6M$89.6M−$76.1M$11.0M−$17.9M
EPS (diluted)$-0.88$-0.68$-0.25$-0.70——
Shares out.220.5M199.7M174.3M149.4M132.8M132.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2022
Operating margin
−203.1%
Net margin
−204.9%
Return on equity
−143.1%
Return on assets
−63.9%
Return on capital (ROCE)
−97.3%
Liabilities / assets
55.3%
Debt / equity
1.24×
Book value / share
$0.71
Revenue growth (YoY)
55.7%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2022
Altman Z″ (distress)
-15.81distress
Accruals / assets
2.0%clean
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
48
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 33Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 3 warning● 2 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.